Crestat Diagnostics, Inc.

Crestat Diagnostics, Inc. — FDA 510(k) Submissions

Crestat Diagnostics, Inc. has submitted 29 FDA 510(k) premarket notifications since 1990, of which 29 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Method, Nephelometric, Immunoglobulins (g, A, M), Alpha-1-lipoprotein, Antigen, Antiserum, Control, Complement C4, Antigen, Antiserum, Control, Diazo Colorimetry, Bilirubin, C-reactive Protein, Antigen, Antiserum, And Control . Use the specialty filter in the sidebar to narrow results.